Browse
Browse
Home
People
Organizations
Research
Events
Capability Map
BREAST CANCER INTERNATIONAL RESEARCH GROUP
Funding Organization
Temporal Graph
Map of Science
Research
Research
Awards Grant
A Multicenter Phase III Randomized Trial Comparing Docetaxel in Combination with Doxorubicin and Cyclophosphamide (TAC) Versus Doxorubicin and Cyclophosphamide Followed by Docetaxel (AC--T) as Adjuvant Treatment of Operable Breast Cancer HER2Neu Negative Patients with Positive Axillary Lymph Nodes
